Sarcoma News

The investigational hallucinogenic drug psilocybin reduced clinician- and patient-reported depression, anxiety and mortality-associated anxiety among adults with cancer, according to results of a small double blind study.

Fewer than half of childhood cancer survivors receive recommended long-term follow-up care, according to findings of a study led by researchers at Roswell Park Cancer Institute.

The implementation of a simple technology to collect and store patient-reported outcomes could improve patients’ quality of life and outcomes and enhance patient–provider communication, according to Ethan Basch, MD, MSc, director of UNC Lineberger Cancer Outcomes Research program.

The number of cancer survivors in the United States is projected to swell from 15.5 million in 2016 to more than 26 million by 2040.

Click here to read the Cover Story, "‘Silver tsunami’ requires ‘all-hands-on-deck’ approach to cancer survivorship"

The American Academy for Cancer Research released the first set of cancer genomic data from Project GENIE, a multiphase, international data-sharing effort.

Richard Gorlick , MD, has been named division head and department chair of pediatrics at The University of Texas MD Anderson Cancer Center.

A steady decline in smoking and advances in early detection and treatment have contributed to a 25% reduction in cancer death rates in the United States since 1991, according to Cancer Statistics 2017, the American Cancer Society’s comprehensive annual report on cancer incidence, mortality and survival.

The Fred Hutchinson Cancer Research Center announced the official opening of a first-of-its-kind clinic dedicated to providing cellular-based immunotherapies for patients with cancer.

SAN DIEGO — Children with cancer had worse outcomes if they had symptomatic venous thrombotic events, according to results of a population-based study conducted in the Maritimes, Canada presented at the ASH Annual Meeting and Exposition.